- Home
- TERN vs CSQ Comparison
TERN vs CSQ Comparison
Compare TERN & CSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TERN | CSQ |
|---|---|---|
| Founded | 2017 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 3.0B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | TERN | CSQ |
|---|---|---|
| Price | $42.98 | $18.32 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $48.60 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 233.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.53% |
| EPS Growth | ★ 11.81 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.87 | $13.11 |
| 52 Week High | $48.26 | $19.83 |
Technical Indicators
Market Signals| Indicator | TERN | CSQ |
|---|---|---|
| Relative Strength Index (RSI) | 67.72 | 33.07 |
| Support Level | $39.15 | $18.30 |
| Resistance Level | $48.26 | $18.59 |
| Average True Range (ATR) | 2.29 | 0.26 |
| MACD | 0.20 | -0.05 |
| Stochastic Oscillator | 85.85 | 3.54 |
Price Performance
Historical ComparisonAbout TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.
About CSQ Calamos Strategic Total Return
Calamos Strategic Total Return Fund is a diversified, closed-end management investment company. The fund's objective is to provide total return through a combination of capital appreciation and current income. Its investment portfolio comprises equities, convertible securities, and high-yield corporate bonds.